Objectives: The degree to which the allocation of disease-specific research funding by the NIH is proportional to disease burden is an important question. This study examined the historical relationship between NIH funding allocation and disease burden for a variety of medical conditions.

Study Design: Coefficients of relatedness for the linear relationships between funding and disease burden for 27 medical conditions over a period exceeding twenty years were calculated.

Methods: Publicly available data from 2009 to 2019, and previously published data from 1994 to 2004, was obtained to compare disease-specific research funding from the NIH to burden of disease values (mortality, prevalence, incidence, DALYs, and YLLs) for 27 diseases.

Results: We identified very weak and declining correlations (e.g., R < 0.03) between funding and the five measures of burden for the 27 diseases. The weak relationships persist even when HIV/AIDS is omitted (e.g., R < 0.1). A recent decline in the overall strengths of the funding burden relationships is attributable to novel investment in Alzheimer's disease research.

Conclusions: The weak correlations reveal long-standing inefficiencies in the NIH disease funding allocation process. The recent increased and focused funding for Alzheimer's disease may not be justified by an objective analysis which considers disease burdens. Increased efficiency of medical research may be realized by improving the poor match between disease burden and funding allocation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11754078PMC
http://dx.doi.org/10.1016/j.puhip.2024.100580DOI Listing

Publication Analysis

Top Keywords

disease burden
12
nih funding
8
funding disease
8
disease-specific funding
8
funding nih
8
funding
5
disease
5
persistence low
4
low correlations
4
nih
4

Similar Publications

Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis.

Emerg Microbes Infect

January 2025

Key Laboratory of Jiangxi Province for Transfusion Medicine, Department of Blood Transfusion, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China.

The tRNA-derived small RNAs (tsRNAs) are a new class of non coding RNAs, which are stable in body fluids and can be used as potential biomarkers for disease diagnosis. However, the exact value of tsRNAs in the diagnosis of tuberculosis (TB) is still unclear. The objective of the present study was to evaluate the performance of the serum tsRNAs biosignature to distinguish between active TB, healthy controls, latent TB infection, and other respiratory diseases.

View Article and Find Full Text PDF

Background: To investigate the trends in Burkitt lymphoma incidence, mortality, and disability-adjusted life-years, considering sex and age, from 1990 to 2021, with a 20-year forecast.

Method: Data regarding Burkitt lymphoma were extracted from the Global Burden of Disease study for the year 2021.

Results: Globally, there were 19,072 incident cases of Burkitt lymphoma in 2021.

View Article and Find Full Text PDF

Background: There is no consensus regarding the optimal regimen for metastatic nasopharyngeal carcinoma (dmNPC). Locoregional intensity modulated radiotherapy (LRRT) following palliative chemotherapy (PCT) has been shown to prolong the overall survival (OS) and improve the progression-free survival (PFS) of patients with dmNPC, compared with PCT alone. However, patients with a high tumor burden do not benefit from additional LRRT, which inevitably results in toxicity.

View Article and Find Full Text PDF

Introduction: Atopic dermatitis (AD), a common dermatological condition, is often associated with significant economic and social burdens. Despite extensive studies globally, there is a gap in understanding the impact of this condition in Romania. This study evaluated the economic burden of AD in Romania, considering both direct and indirect costs.

View Article and Find Full Text PDF

Introduction: Low grade appendiceal mucinous neoplasms (LAMN) are indolent tumors that lack invasive potential but may present as pseudomyxoma peritonei. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) significantly improves both overall and recurrence free survival. While systemic chemotherapy is generally considered ineffective for LAMN, little literature is available to support this notion.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!